{"id":"W2912598520","doi":"10.1080/10428194.2018.1498490","title":"Improving CD20 antibody therapy: obinutuzumab in lymphoproliferative disorders","year":2019,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Obinutuzumab; Rituximab; Medicine; Chronic lymphocytic leukemia; CD20; Follicular lymphoma; Lymphoma; Immunology; Antibody; Monoclonal antibody; Lymphoproliferative disorders; Oncology; Internal medicine; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006011866,0.0007024762,0.00133414,0.002707944,0.0002248617,0.0009011517,0.000951454,0.001059782,0.003199279],"category_scores_gemma":[0.0007581287,0.0002080653,0.0006039505,0.002104139,0.0003466999,0.001073654,0.0006447186,0.001753598,0.00124065],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006454902,"about_ca_system_score_gemma":0.0008223057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009874287,"about_ca_topic_score_gemma":0.002058872,"domain_scores_codex":[0.9997708,0.00005627321,0.0000347211,0.00003119638,0.00008313198,0.00002388108],"domain_scores_gemma":[0.9997512,0.0001182518,0.00004460975,0.000006645676,0.00005787947,0.00002144539],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008263886,0.00004906086,0.0001051273,0.02112319,0.0001405516,0.0001371383,0.00005000079,0.0002596139,0.0006390305,0.001827642,0.02981191,0.945774],"study_design_scores_gemma":[0.00004830137,0.00009090549,0.0007358487,0.01122047,0.0002618926,0.001451815,0.00005016349,0.00009839807,0.0003005363,0.001922313,0.9838054,0.00001390057],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005207821,0.9994152,0.00002968428,0.0001251342,0.00009126101,0.000002086047,0.000005002191,0.000002652401,0.0002768301],"genre_scores_gemma":[0.0004196313,0.9990169,0.00006758492,0.0001507525,0.0001000439,0.000003097134,0.00001369382,8.535228e-7,0.0002274295],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003199279,"threshold_uncertainty_score":0.01070267,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03349201169399164,"score_gpt":0.3415532246328902,"score_spread":0.3080612129388986,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}